Ameriprise Financial Inc Harmony Biosciences Holdings, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 85,071 shares of HRMY stock, worth $2.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,071

Previous 88,045 3.38%

Holding current value

$2.81 Million

Previous $2.66 Million 27.94%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $89,220 - $118,811	-2,974 Reduced 3.38%	85,071 $3.4 Million
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $204,695 - $234,536	-7,105 Reduced 7.47%	88,045 $2.66 Million
Q1 2024 May 15, 2024	SELL	$29.93 - $35.06 $117,205 - $137,294	-3,916 Reduced 3.95%	95,150 $3.2 Million
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $217,363 - $382,423	-11,321 Reduced 10.26%	99,066 $3.2 Million
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $53,096 - $64,984	1,665 Added 1.53%	110,387 $3.62 Million
Q2 2023 Aug 14, 2023	SELL	$30.5 - $37.4 $44,835 - $54,978	-1,470 Reduced 1.33%	108,722 $3.83 Million
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $1.67 Million - $2.92 Million	-54,190 Reduced 32.97%	110,192 $3.6 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $1.22 Million - $1.63 Million	26,779 Added 19.46%	164,382 $9.06 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $1.79 Million - $2.36 Million	42,478 Added 44.65%	137,603 $6.1 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $23,478 - $36,505	700 Added 0.74%	95,125 $4.64 Million
Q1 2022 May 16, 2022	SELL	$33.14 - $51.13 $265 - $409	-8 Reduced 0.01%	94,425 $4.59 Million
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $3.22 Million - $4.15 Million	94,433 New	94,433 $4.03 Million

Others Institutions Holding HRMY

# of Institutions

240

Shares Held

45.2M

Call Options Held

103K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.95B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Harmony Biosciences Holdings, Inc. Transaction History